Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
- PMID: 25254005
- PMCID: PMC4171668
- DOI: 10.5114/pdia.2014.40925
Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
Abstract
Introduction: Androgenetic alopecia (AGA) is the most common form of hair loss. Clinically observed hair loss is due to the continuous miniaturization of affected hair follicles. Genetic factors and androgenic factors especially dihydrotestosterone (DHT), which is a testosterone tissue metabolite, play major roles in the pathogenesis of AGA. However, expert opinions about the usefulness of DHT in the diagnosis of this type of alopecia are divided.
Aim: To evaluate the usefulness of DHT level in patients with androgenetic alopecia compared with the control group.
Material and methods: The study comprised 49 subjects: 19 women and 9 men with androgenetic alopecia. The control group consisted of 17 healthy women and 4 men without hair loss.
Results: Increased serum concentrations of DHT were observed in patients with androgenetic alopecia (17 women, 5 men), but also in the control group. The differences in mean values of DHT were not significant according to the types of alopecia and the control group. Increased serum concentrations of DHT were not correlated with the advance of alopecia.
Conclusions: Dihydrotestosterone is the most influential androgen and seems to play a very important role in the pathogenesis of androgenetic alopecia. Based on the results of our study and others, the most important factors would appear to be the genetically-determined sensitivity of the follicles to DHT and their different reactions to androgen concentration.
Keywords: androgenetic alopecia; diagnostic; dihydrotestosterone.
Figures
Similar articles
-
Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia.Biomed Pharmacother. 2021 May;137:111247. doi: 10.1016/j.biopha.2021.111247. Epub 2021 Jan 29. Biomed Pharmacother. 2021. PMID: 33517191
-
[Hormonal interaction and hair growth].Ann Dermatol Venereol. 2002 May;129(5 Pt 2):787-92. Ann Dermatol Venereol. 2002. PMID: 12223960 Review. French.
-
Serum androgens and prostate-specific antigen levels in androgenetic alopecia: is there a difference between frontal and vertex baldness?J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1815-1818. doi: 10.1111/jdv.14758. Epub 2018 Jan 12. J Eur Acad Dermatol Venereol. 2018. PMID: 29237093
-
Androgenetic alopecia in women and men: Italian guidelines adapted from European Dermatology Forum/European Academy of Dermatology and Venereology guidelines.G Ital Dermatol Venereol. 2020 Oct;155(5):622-631. doi: 10.23736/S0392-0488.19.06399-5. G Ital Dermatol Venereol. 2020. PMID: 33295740
-
An overview of herbal alternatives in androgenetic alopecia.J Cosmet Dermatol. 2019 Aug;18(4):966-975. doi: 10.1111/jocd.12930. Epub 2019 Apr 13. J Cosmet Dermatol. 2019. PMID: 30980598 Review.
Cited by
-
Hair Growth-Promoting Activities of Glycosaminoglycans Extracted from the Tunics of Ascidian (Halocynthia roretzi).Polymers (Basel). 2022 Mar 9;14(6):1096. doi: 10.3390/polym14061096. Polymers (Basel). 2022. PMID: 35335427 Free PMC article.
-
Development of finasteride polymer microspheres for systemic application in androgenic alopecia.Int J Mol Med. 2019 Jun;43(6):2409-2419. doi: 10.3892/ijmm.2019.4149. Epub 2019 Mar 28. Int J Mol Med. 2019. PMID: 30942390 Free PMC article.
-
Comprehensive transcriptome profiling between balding and non-balding scalp of female pattern hair loss in Asian.Arch Dermatol Res. 2024 Jun 8;316(7):360. doi: 10.1007/s00403-024-03114-w. Arch Dermatol Res. 2024. PMID: 38850442
-
Gynostemma pentaphyllum Hydrodistillate and Its Major Component Damulin B Promote Hair Growth-Inducing Properties In Vivo and In Vitro via the Wnt/β-Catenin Pathway in Dermal Papilla Cells.Nutrients. 2024 Mar 28;16(7):985. doi: 10.3390/nu16070985. Nutrients. 2024. PMID: 38613018 Free PMC article.
-
Serum Levels of Androgen-Associated Hormones Are Correlated with Curative Effect in Androgenic Alopecia in Young Men.Med Sci Monit. 2018 Oct 30;24:7770-7777. doi: 10.12659/MSM.913116. Med Sci Monit. 2018. PMID: 30376555 Free PMC article.
References
-
- Kozłowska U, Kozłowska A. Pathophysiology of growth and hair loss [Polish] Przegl Dermatol. 2001;1:19–25.
-
- Kozłowska U, Kozłowska A. The clinical picture and the treatment of the most common form of alopecia [Polish] Przegl Dermatol. 2001;4:311–20.
-
- Brzezińska-Wcisło L, Lis-Święty A, Wcisło-Dziadecka D, et al. What's new in the pathogenesis and treatment of androgenetic alopecia in men [Polish] Derm Klin. 2007;9:179–81.
-
- Randall VA. Androgens and hair growth. Dermatol Ther. 2008;21:314–28. - PubMed
-
- Alsantali A, Shapiro J. Androgens and hair loss. Curr Opin Endocrinol Diabetes Obes. 2009;16:246–53. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous